查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715628

萤光素酶检测市场按产品类型、检测类型、检测仪器、技术、研究领域、应用和最终用户划分－2025-2030 年全球预测

Luciferase Assays Market by Product Type, Assay Types, Detection Instruments, Technology, Research Areas, Applications, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计萤光素酶检测市场在 2024 年的价值将达到 17.2 亿美元，在 2025 年将成长至 18.4 亿美元，在 2030 年将达到 26.9 亿美元，复合年增长率为 7.71%。

主要市场统计数据
基准年2024年 17.2亿美元
预计2025年 18.4亿美元
预测年份 2030 26.9亿美元
复合年增长率（%） 7.71%

萤光素酶检测是现代分子研究的基石，结合最尖端科技来量化生物询问和细胞过程。这些分析利用生物发光来揭示基因表现、酵素活性和众多讯号路径的复杂细节。在精确度至关重要的时代，这些技术为研究人员提供了无与伦比的灵敏度和快速的数据生成。

随着分析化学和仪器的重大创新，它的应用也蓬勃发展，从而提高了学术和工业环境的效率。透过提供即时分析和高通量能力，萤光素酶检测弥补了传统实验室技术与现代自动化系统之间的差距。本介绍为理解由技术进步、监管变化和对强大的科学解决方案日益增长的需求所塑造的细微的市场动态奠定了基础。

随着市场的不断发展，相关人员越来越需要探索融合科学严谨性和商业性敏锐性的多面向环境。该检测在药物发现、毒性测试和基础研究中的效用凸显了其在推动生物医学科学和治疗创新方面的关键作用。因此，市场相关人员面临挑战和机会，需要深入了解新兴趋势和细分洞察。

不断变化的格局：技术与市场变化

近年来，在快速的技术创新和不断变化的消费者需求的推动下，萤光素酶检测市场正在转变。自动化系统的整合不仅增加了分析过程的吞吐量，而且提高了资料收集和分析的准确性。这些进步推动了从传统手动方法向复杂的全自动平台的转变，从而大大减少了检测时间和可变性。

这种转变的一个关键方面源于试剂配方的改进，这提高了整体检测的灵敏度和可靠性。下一代萤光素酶和基材的引入使研究人员能够检测到最细微的生物讯号，同时确保实验结果的稳健性和可重复性。此外，数位介面和先进数据分析软体的应用简化了工作流程，并允许将实验数据无缝整合到更大的分析流程中。

市场变化超越了技术进步。越来越多的老牌製药公司和新兴生技公司进入这个市场，消费群也出现了明显的调整。这种双重涌入催生了竞争环境，迫使企业不仅要进行技术创新，还要改善市场策略。新兴企业正在利用基因表现和蛋白质交互作用研究中的利基应用，从而挑战传统市场领导不断改进其产品。

行业相关人员也见证了成本压力与追求更高性能之间的动态相互作用。随着资金筹措状况的演变，人们需要具有成本效益且高品质的检测系统。这导致了跨部门合作，将学术见解和工业规模製造结合在一起，以生产高效、适合市场的检测解决方案。简而言之，不断变化的产业格局反映出一个产业不断追求卓越和业务效率。

揭示详细的细分洞察

对萤光素酶检测市场进行全面分析，揭示了复杂的细分市场，可作为了解市场动态的蓝图。从产品角度来看，市场复杂地细分为仪器、套件和试剂以及软体和服务。仪器类别包括光度计和微孔盘读数仪，这两者对于准确捕捉生物发光讯号至关重要。谈到套件和试剂，重点是萤光素酶和基材试剂，它们各自在优化检测性能方面发挥重要作用。软体和服务也占据有利地位，数据分析工具和技术支援服务对于确保无缝分析的执行和解释至关重要。

生物发光、化学发光和双报告分析分别针对不同的实验设计和目标。当考虑检测设备时，流式细胞技术系统、光度计和微孔盘读数仪的使用可以对数据的生成和处理方式提供细緻的理解。在更广泛的技术领域内，自动化系统和手动系统之间存在明显的区别，凸显了产业对效率和精确度的需求。

依研究领域进一步分类发现，该检测在心血管疾病、中枢神经系统疾病、感染疾病和肿瘤学研究方面具有重要应用。每个研究领域都受益于萤光素酶检测提供的详细分析，这使得它们成为研究复杂生物学问题的研究人员的最爱。基于应用的细分透过结合药物传输机制、酵素活性分析、基因表现、蛋白质-蛋白质交互作用、讯号路径分析等不同的研究目标，进一步细化了市场研究。值得注意的是，酵素活性分析进一步细分为动力学研究和基材鑑定，突显了该领域分析能力的深度。

最后，根据最终用户进行细分显示，学术研究机构、生技公司、受託研究机构和製药公司是萤光素酶检测的主要受益者。在学术研究机构内，进一步划分为研究生实验室和本科课程，这表明在教育环境中引入萤光素酶检测的方式存在层次结构。这种多方面的细分有助于市场细分利益相关人员清楚地了解市场机会和潜在的成长领域。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 政府和私部门研发投资激增
      • 个人化医疗的发展推动了萤光素酶检测的使用和改进
      • 慢性病盛行率的上升推动了对高效诊断的需求
    • 限制因素
      • 成本和复杂性如何影响萤光素酶检测的采用
    • 机会
      • 投资高通量筛检技术，扩大萤光素酶检测的应用范围
      • 开发基于萤光素酶的检测试剂套件以支持兽医诊断的快速检测
    • 任务
      • 对供应链中断影响萤光素酶检测试剂供应的担忧
  • 市场区隔分析
    • 产品类型：在检测设定和执行中发挥重要作用的仪器和套件的需求日益增长
    • 最终用户：製药公司快速效用萤光素酶检测
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 萤光素酶检测市场（依产品类型）

  • 装置
    • 光度计
    • 微孔盘读数仪
  • 套件和试剂
    • 萤光素酶试剂
    • 基材试剂
  • 软体和服务
    • 数据分析软体
    • 技术支援服务

7. 萤光素酶检测市场（依检测类型）

  • 生物发光试验
  • 化学冷光分析
  • 双报告基因检测

8. 萤光素酶检测市场（依检测仪器）

  • 流式细胞技术系统
  • 光度计
  • 微孔盘读数仪

9. 萤光素酶检测市场（依技术）

  • 自动化系统
  • 手动系统

第 10 章 萤光素酶检测市场区隔研究

  • 心血管疾病
  • 中枢神经系统疾病
  • 感染疾病
  • 肿瘤学

第11章 萤光素酶检测市场（依应用）

  • 药物输送机制
  • 酵素活性分析
    • 运动学研究
    • 基材识别
  • 基因表现
  • 蛋白质-蛋白质相互作用
  • 讯号通路分析

第 12 章 萤光素酶检测市场（依最终用户）

  • 学术研究所
    • 研究生院研究办公室
    • 大学部课程
  • 生技公司
  • 合约研究组织
  • 製药公司

13.美洲萤光素酶检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

14. 亚太地区萤光素酶检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

15. 欧洲、中东和非洲萤光素酶检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Active Motif, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BMG LABTECH GmbH
  • Danaher Corporation
  • Enzo Life Sciences, Inc.
  • Genecopoeia, Inc.
  • Indigo Biosciences, Inc.
  • InvivoGen SAS
  • Lonza Group AG
  • Merck KGaA
  • New England Biolabs, Inc.
  • PerkinElmer, Inc.
  • Promega Biosciences LLC
  • Promega Corporation
  • Qiagen NV
  • Roche Holding AG
  • Sartorius AG
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-0302D35AB53D

The Luciferase Assays Market was valued at USD 1.72 billion in 2024 and is projected to grow to USD 1.84 billion in 2025, with a CAGR of 7.71%, reaching USD 2.69 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.72 billion
Estimated Year [2025] USD 1.84 billion
Forecast Year [2030] USD 2.69 billion
CAGR (%) 7.71%

Luciferase assays represent a cornerstone in modern molecular research, merging biological inquiry with cutting-edge technology to quantify cellular processes. These assays harness bioluminescence to reveal intricate details of gene expression, enzyme activity, and numerous signal transduction pathways. In an era where precision is paramount, these technologies offer researchers unparalleled sensitivity and rapid data generation.

Their adoption has surged alongside significant innovations in assay chemistry and instrumentation, leading to enhanced efficiency in both academic and industrial settings. By providing real-time analysis and high-throughput capabilities, luciferase assays bridge the gap between traditional experimental methods and contemporary automated systems. This introduction lays the foundation for understanding the nuanced market dynamics shaped by technological advancements, regulatory changes, and a growing demand for robust scientific solutions.

As the market continues to evolve, stakeholders are increasingly required to navigate a multifaceted landscape that blends scientific rigor with commercial acumen. The pertinence of these assays in drug discovery, toxicity testing, and basic research underlines their critical role in advancing biomedical science and therapeutic innovation. As a result, market players are presented with both challenges and opportunities that necessitate a deep understanding of emerging trends and segmentation insights.

Transforming the Landscape: Technological and Market Shifts

Over recent years, the luciferase assays market has undergone transformative shifts driven by rapid technological innovation and evolving consumer needs. The integration of automated systems has not only increased the throughput of assay procedures but has also refined the precision with which data is captured and analyzed. These advancements have propelled the transition from conventional manual methods to sophisticated, fully automated platforms that significantly reduce assay time and variability.

A pivotal aspect of this transformation stems from improvements in reagent formulations, which have enhanced the overall sensitivity and reliability of the assays. The introduction of next-generation luciferase enzymes and substrates has allowed researchers to detect even the most minute biological signals, ensuring that experimental outcomes are both robust and reproducible. Furthermore, the adaptation of digital interfaces and advanced data analysis software has streamlined the workflow, enabling seamless integration of experimental data into larger analytical pipelines.

Market shifts are not limited to technological enhancements. There has been a pronounced realignment in the consumer base, with increased participation from both established pharmaceutical companies and emerging biotechnology firms. This dual influx is driving a competitive environment where companies are not only innovating on the technology front but are also refining their market strategies. Emergent players are leveraging niche applications in gene expression and protein interaction studies, thereby challenging traditional market leaders to continuously improve their offerings.

Industry actors are also witnessing a dynamic interplay between cost pressures and the quest for higher performance. As funding landscapes evolve, cost-effective yet high-quality assay systems have become a necessity. This has led to collaborations across different sectors, where academic insights and industrial scale manufacturing converge to produce efficient and market-responsive assay solutions. In essence, the transformative shifts in the landscape reflect an industry in vigorous pursuit of excellence and operational efficiency.

In-depth Segmentation Insights Unveiled

A comprehensive analysis of the luciferase assays market reveals a sophisticated segmentation landscape that serves as a blueprint for understanding the underlying market dynamics. From a product standpoint, the market is intricately segmented into instruments, kits and reagents, and software and services. The instruments category encompasses luminometers and microplate readers, both of which are vital for accurately capturing bioluminescent signals. Moving to kits and reagents, the focus narrows down to luciferase enzyme reagents and substrate reagents, each playing a critical role in optimizing assay performance. Software and services have also carved out their niche, with data analysis tools and technical support services becoming indispensable for ensuring seamless assay execution and interpretation.

The market also differentiates itself based on assay types, with bioluminescence assays, chemiluminescence assays, and dual reporter assays each catering to distinct experimental designs and objectives. When considering detection instruments, the use of flow cytometry systems, luminometers, and microplate readers offers a nuanced understanding of how data is generated and processed. Under the broad umbrella of technology, a clear distinction is made between automated and manual systems, highlighting the industry's move towards efficiency and precision.

Further segmentation by research areas demonstrates that the assays have significant applications in studying cardiovascular diseases, central nervous system disorders, infectious diseases, and oncology. Each research area benefits from the detailed analysis provided by luciferase assays, making them a favorite among researchers tackling complex biological questions. Applications-based segmentation further refines the market study by incorporating diverse research objectives such as drug delivery mechanisms, enzyme activity analysis, gene expression, protein-protein interactions, and signal pathway analysis. It is noteworthy that enzyme activity analysis is given additional granularity through kinetic studies and substrate identification, which underscores the depth of analytical capability within this segment.

Finally, segmentation based on end users reveals that academic research institutes, biotechnology companies, contract research organizations, and pharmaceutical companies are the primary beneficiaries of luciferase assays. Within academic research institutes, there is a further breakdown into postgraduate research labs and undergraduate programs, indicating a layered approach to how these assays are deployed in educational settings. This multi-dimensional segmentation provides industry stakeholders with a clear picture of market opportunities and potential areas for growth.

Based on Product Type, market is studied across Instruments, Kits and Reagents, and Software and Services. The Instruments is further studied across Luminometers and Microplate Readers. The Kits and Reagents is further studied across Luciferase Enzyme Reagents and Substrate Reagents. The Software and Services is further studied across Data Analysis Software and Technical Support Services.

Based on Assay Types, market is studied across Bioluminescence Assays, Chemiluminescence Assays, and Dual Reporter Assays.

Based on Detection Instruments, market is studied across Flow Cytometry Systems, Luminometers, and Microplate Readers.

Based on Technology, market is studied across Automated Systems and Manual Systems.

Based on Research Areas, market is studied across Cardiovascular Diseases, CNS Disorders, Infectious Diseases, and Oncology.

Based on Applications, market is studied across Drug Delivery Mechanisms, Enzyme Activity Analysis, Gene Expression, Protein-Protein Interaction, and Signal Pathway Analysis. The Enzyme Activity Analysis is further studied across Kinetic Studies and Substrate Identification.

Based on End Users, market is studied across Academic Research Institutes, Biotechnology Companies, Contract Research Organizations, and Pharmaceutical Companies. The Academic Research Institutes is further studied across Postgraduate Research Labs and Undergraduate Programs.

Regional Market Trends and Global Reach

A regional analysis of the luciferase assays market offers valuable insights into the geographical distribution of demand and innovation. The market dynamics in the Americas have experienced notable growth, underpinned by robust investments in research infrastructure and rapid adoption of advanced assay technologies within both academic and industrial laboratories. Research-driven economies in North America continue to contribute significantly to innovation in assay platforms, driven by high research expenditure and government support.

In the combined market of Europe, the Middle East, and Africa, there is a strong emphasis on regulatory compliance and quality assurance. This region witnesses a balanced distribution of high-end research activities alongside strategic collaborations geared towards translational research. The implementation of stringent quality benchmarks and sustained public-private partnerships in these areas has facilitated a favorable climate for introducing and scaling advanced assay systems.

The Asia-Pacific region represents one of the most dynamic and rapidly evolving markets. With an increasing allocation of resources towards scientific research and development, coupled with a growing pool of skilled laboratory professionals, this region is emerging as a global hub for innovation. The competitive landscape here is bolstered by both indigenous companies and multinational corporations, all of which are striving to meet the evolving demands of a diverse customer base. These regional insights underscore the varied yet interconnected market trends that drive the global adoption of luciferase assays, reflecting unique regional priorities and strategic initiatives.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Players Shaping the Market Landscape

In the competitive arena of luciferase assays, several companies have distinguished themselves through technological innovation, strategic collaborations, and robust market presence. Industry leaders such as Active Motif, Inc. and Agilent Technologies, Inc. have consistently pushed the boundaries of assay technology, delivering state-of-the-art solutions that cater to the increasingly sophisticated needs of the research community. Major corporations like Becton, Dickinson and Company, and Bio-Rad Laboratories, Inc. have invested heavily in the development of both hardware and reagent innovations, ensuring that their offerings remain at the forefront of scientific inquiry.

Other influential market players include BMG LABTECH GmbH and Danaher Corporation, whose commitment to precision and high-throughput capabilities has set new benchmarks in the detection and quantification arena. Enzo Life Sciences, Inc. and Genecopoeia, Inc. are also notable for addressing niche market segments, while companies like Indigo Biosciences, Inc. and InvivoGen S.A.S. continue to drive significant advancements in assay reagents and protocols. Lonza Group AG, Merck KGaA, and New England Biolabs, Inc. have underscored their capabilities by blending scientific expertise with extensive customer support services, further solidifying their positions in a competitive market.

The landscape is further enriched by the contributions of PerkinElmer, Inc., Promega Biosciences LLC, and Promega Corporation, each known for their comprehensive product portfolios and innovative solutions that span from basic research to high-end clinical applications. Qiagen N.V., Roche Holding AG, and Sartorius AG leverage their extensive global networks to offer localized support and training, ensuring that their products are well-integrated into diverse research ecosystems. Additionally, Takara Bio Inc., Tecan Group Ltd., and Thermo Fisher Scientific Inc. have demonstrated consistent growth in market share by focusing on customer-centric innovations and robust after-sales support, reflecting a deep understanding of the evolving needs of modern laboratories.

These companies have not only driven technological progress but have also contributed to shaping market trends through strategic product launches and innovation in application areas, thereby impacting the market's overall trajectory. Their influence is evident in both legacy systems and cutting-edge technologies, illustrating their central role in facilitating advancements in luciferase assay methodologies.

The report delves into recent significant developments in the Luciferase Assays Market, highlighting leading vendors and their innovative profiles. These include Active Motif, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BMG LABTECH GmbH, Danaher Corporation, Enzo Life Sciences, Inc., Genecopoeia, Inc., Indigo Biosciences, Inc., InvivoGen S.A.S., Lonza Group AG, Merck KGaA, New England Biolabs, Inc., PerkinElmer, Inc., Promega Biosciences LLC, Promega Corporation, Qiagen N.V., Roche Holding AG, Sartorius AG, Takara Bio Inc., Tecan Group Ltd., and Thermo Fisher Scientific Inc.. Strategic Recommendations for Industry Leaders

Industry leaders looking to navigate the competitive landscape of luciferase assays are advised to focus on fostering innovation, expanding product portfolios, and enhancing customer engagement. A strategic emphasis on research and development will be crucial in creating next-generation assay solutions that address both current challenges and future market needs. Leaders should invest in state-of-the-art automated systems and data analytics tools to improve the precision and efficiency of assay processes, thereby reducing experimental variability and accelerating time-to-result.

It is equally important to deepen market penetration by tailoring solutions to meet the specific demands of diverse research segments. Special attention should be given to segments such as enzyme activity analysis, where nuanced sub-categories like kinetic studies and substrate identification demand highly specialized technical reagents and protocols. By customizing product development and support services to target academic research institutes, biotechnology companies, contract research organizations, and pharmaceutical companies, organizations can enhance customer satisfaction and foster long-term loyalty.

Moreover, forging strategic partnerships across geographical and disciplinary boundaries can provide a competitive edge. Collaborations with regional laboratories, academic institutions, and clinical research centers will not only broaden market access but also facilitate the exchange of innovative ideas and best practices. Concurrently, companies should augment their training initiatives and technical support frameworks to empower users, ensuring they can fully leverage the advanced capabilities of new assay systems.

A proactive approach to compliance with evolving regulatory standards is also essential. Industry leaders should maintain an agile strategy that anticipates regulatory changes and incorporates cutting-edge quality control measures into product development. By investing in robust validation protocols and maintaining transparency in data reporting, companies can build trust and credibility with stakeholders while minimizing operational risks in an increasingly regulated environment.

Conclusion and Future Outlook

The landscape of luciferase assays is characterized by rapid technological advancements, strategic market realignments, and a robust growth trajectory driven by both innovation and demand diversity. As the industry continues to evolve, the integration of automated systems, enhanced reagent formulations, and advanced data analytics will further propel assay capabilities. The thorough analysis of market segmentation reveals that whether through advancements in instrumentation, detailed research application strategies, or tailored support for diverse end users, the market is positioned at the cusp of remarkable transformation.

Looking ahead, companies that harness the power of collaboration, innovation, and strategic market understanding will be best equipped to meet the challenges and opportunities of tomorrow. As scientific inquiry pushes the boundaries of what is possible, the future of luciferase assays will depend on continuous improvements in precision, efficiency, and scalability. This dynamic interplay of technology and market demand signals promising opportunities for both established players and emerging innovators, setting a vibrant course for future developments in the field.

In summary, the evolution of luciferase assays is a testament to the synergy between technological ingenuity and market-driven needs, offering a blueprint for sustainable growth and lasting scientific impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surging investment in research and development from government and private sectors
      • 5.1.1.2. Growth in personalized medicine encouraging the use and refinement of luciferase assays
      • 5.1.1.3. Rising prevalence of chronic diseases driving the need for efficient diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Impact of cost and complexity on the widespread adoption of luciferase assays
    • 5.1.3. Opportunities
      • 5.1.3.1. Investing in high-throughput screening technologies to increase luciferase assay applications
      • 5.1.3.2. Development of luciferase-based assay kits supporting rapid testing in veterinary diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding supply chain disruptions impacting luciferase assay reagent availability
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product type: Growing demand for instruments and kits for its foundational role in assay setup and execution
    • 5.2.2. End users: Rapid utility of luciferase assays in pharmaceutical companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Luciferase Assays Market, by Product Type

  • 6.1. Introduction
  • 6.2. Instruments
    • 6.2.1. Luminometers
    • 6.2.2. Microplate Readers
  • 6.3. Kits and Reagents
    • 6.3.1. Luciferase Enzyme Reagents
    • 6.3.2. Substrate Reagents
  • 6.4. Software and Services
    • 6.4.1. Data Analysis Software
    • 6.4.2. Technical Support Services

7. Luciferase Assays Market, by Assay Types

  • 7.1. Introduction
  • 7.2. Bioluminescence Assays
  • 7.3. Chemiluminescence Assays
  • 7.4. Dual Reporter Assays

8. Luciferase Assays Market, by Detection Instruments

  • 8.1. Introduction
  • 8.2. Flow Cytometry Systems
  • 8.3. Luminometers
  • 8.4. Microplate Readers

9. Luciferase Assays Market, by Technology

  • 9.1. Introduction
  • 9.2. Automated Systems
  • 9.3. Manual Systems

10. Luciferase Assays Market, by Research Areas

  • 10.1. Introduction
  • 10.2. Cardiovascular Diseases
  • 10.3. CNS Disorders
  • 10.4. Infectious Diseases
  • 10.5. Oncology

11. Luciferase Assays Market, by Applications

  • 11.1. Introduction
  • 11.2. Drug Delivery Mechanisms
  • 11.3. Enzyme Activity Analysis
    • 11.3.1. Kinetic Studies
    • 11.3.2. Substrate Identification
  • 11.4. Gene Expression
  • 11.5. Protein-Protein Interaction
  • 11.6. Signal Pathway Analysis

12. Luciferase Assays Market, by End Users

  • 12.1. Introduction
  • 12.2. Academic Research Institutes
    • 12.2.1. Postgraduate Research Labs
    • 12.2.2. Undergraduate Programs
  • 12.3. Biotechnology Companies
  • 12.4. Contract Research Organizations
  • 12.5. Pharmaceutical Companies

13. Americas Luciferase Assays Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Luciferase Assays Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Luciferase Assays Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. Promega launches GloMax galaxy imager for enhanced real-time protein analysis
    • 16.3.2. Monod Bio unveils LuxSit Pro, pioneering fully de Novo luciferase for research and diagnostics
    • 16.3.3. FUJIFILM Wako Pure Chemicals unveils advanced pyrogen and endotoxin testing kits
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Active Motif, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BMG LABTECH GmbH
  • 6. Danaher Corporation
  • 7. Enzo Life Sciences, Inc.
  • 8. Genecopoeia, Inc.
  • 9. Indigo Biosciences, Inc.
  • 10. InvivoGen S.A.S.
  • 11. Lonza Group AG
  • 12. Merck KGaA
  • 13. New England Biolabs, Inc.
  • 14. PerkinElmer, Inc.
  • 15. Promega Biosciences LLC
  • 16. Promega Corporation
  • 17. Qiagen N.V.
  • 18. Roche Holding AG
  • 19. Sartorius AG
  • 20. Takara Bio Inc.
  • 21. Tecan Group Ltd.
  • 22. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. LUCIFERASE ASSAYS MARKET MULTI-CURRENCY
  • FIGURE 2. LUCIFERASE ASSAYS MARKET MULTI-LANGUAGE
  • FIGURE 3. LUCIFERASE ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 4. LUCIFERASE ASSAYS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
  • FIGURE 21. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 25. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 29. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 30. LUCIFERASE ASSAYS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 31. LUCIFERASE ASSAYS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. LUCIFERASE ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LUCIFERASE ASSAYS MARKET DYNAMICS
  • TABLE 7. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY LUCIFERASE ENZYME REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY SUBSTRATE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY TECHNICAL SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY BIOLUMINESCENCE ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY CHEMILUMINESCENCE ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY DUAL REPORTER ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY FLOW CYTOMETRY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY CNS DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY DRUG DELIVERY MECHANISMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY KINETIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY SUBSTRATE IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY SIGNAL PATHWAY ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY POSTGRADUATE RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY UNDERGRADUATE PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 164. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 176. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 188. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 200. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 210. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 212. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 222. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 224. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 234. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 235. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 248. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 250. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 257. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 258. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 259. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 260. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 262. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 268. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 269. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 270. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 271. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 272. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 274. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 280. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 281. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 282. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 283. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 297. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 299. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 300. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 301. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 302. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 303. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 304. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 305. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 306. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 307. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 308. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 309. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 311. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 312. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 313. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 314. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 315. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 316. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 317. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 318. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 319. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 320. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 321. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 322. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 323. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 324. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 325. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 326. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 327. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 328. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY RESEARCH AREAS, 2018-2030 (USD MILLION)
  • TABLE 329. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 330. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY ENZYME ACTIVITY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 331. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 332. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 333. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 335. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 336. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
  • TABLE 337. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY ASSAY TYPES, 2018-2030 (USD MILLION)
  • TABLE 338. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY DETECTION INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 339. FRANCE LUCIFERASE ASSAYS MARKET SIZE, B